BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 27598699)

  • 1. A Meta-Analysis of Antiviral Therapy for Hepatitis B Virus-Associated Membranous Nephropathy.
    Yang Y; Ma YP; Chen DP; Zhuo L; Li WG
    PLoS One; 2016; 11(9):e0160437. PubMed ID: 27598699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of hepatitis B virus-associated nephropathy.
    Elewa U; Sandri AM; Kim WR; Fervenza FC
    Nephron Clin Pract; 2011; 119(1):c41-9; discussion c49. PubMed ID: 21677438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful Use of Entecavir in Hepatitis B-associated Membranous Nephropathy.
    Mahajan V; D'Cruz S; Nada R; Sachdev A
    J Trop Pediatr; 2018 Jun; 64(3):249-252. PubMed ID: 28977667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful Treatment of Hepatitis B Virus-associated Membranous Nephropathy with Entecavir and Immunosuppressive Agents.
    Ochi A; Ishimura E; Ichii M; Ohno Y; Nakatani S; Kobayashi I; Shima H; Tsuda A; Shidara K; Mori K; Tamori A; Inaba M
    Nephrology (Carlton); 2014 Sep; 19(9):595-6. PubMed ID: 25156438
    [No Abstract]   [Full Text] [Related]  

  • 5. Hepatitis B virus-related membranous nephropathy treated with entecavir.
    Ikee R; Ishioka K; Oka M; Maesato K; Moriya H; Hidaka S; Ohtake T; Kobayashi S
    Nephrology (Carlton); 2010 Mar; 15(2):266. PubMed ID: 20470290
    [No Abstract]   [Full Text] [Related]  

  • 6. Effectiveness of sulodexide might be associated with inhibition of complement system in hepatitis B virus-associated membranous nephropathy: An inspiration from a pilot trial.
    Yang Y; Ma L; Wang C; Kong D; Wang Y; Mei C
    Eur J Intern Med; 2016 Jul; 32():96-104. PubMed ID: 27160380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Membranous nephropathy related to hepatitis B virus in adults.
    Lai KN; Li PK; Lui SF; Au TC; Tam JS; Tong KL; Lai FM
    N Engl J Med; 1991 May; 324(21):1457-63. PubMed ID: 2023605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Membranous nephropathy associated with chronic hepatitis B occurring in a short period after acute hepatitis B virus infection.
    Nakahara K; Takahashi H; Okuse C; Shigefuku R; Yamada N; Murao M; Matsunaga K; Koike J; Yotsuyanagi H; Suzuki M; Kimura K; Itoh F
    Intern Med; 2010; 49(5):383-8. PubMed ID: 20190469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complete remission of hepatitis B virus-related membranous nephropathy after entecavir monotherapy.
    Yang YF; Xiong QF; Zhao W; Zhong YD
    Clin Res Hepatol Gastroenterol; 2012 Oct; 36(5):e89-92. PubMed ID: 22572521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of anti-viral therapy on hepatitis B virus-associated glomerulonephritis: A systematic review and meta-analysis.
    Yi Z; Jie YW; Nan Z
    Ann Hepatol; 2011; 10(2):165-73. PubMed ID: 21502678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term lamivudine therapy in hepatitis B-associated membranous nephropathy?
    Ng YY; Yang WC; Lee ST
    Kidney Int; 2006 Feb; 69(4):776. PubMed ID: 16518335
    [No Abstract]   [Full Text] [Related]  

  • 12. Meta-analysis of combined therapy for adult hepatitis B virus-associated glomerulonephritis.
    Zheng XY; Wei RB; Tang L; Li P; Zheng XD
    World J Gastroenterol; 2012 Feb; 18(8):821-32. PubMed ID: 22371643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of hepatitis B virus-associated glomerulonephritis: a meta-analysis.
    Zhang Y; Zhou JH; Yin XL; Wang FY
    World J Gastroenterol; 2010 Feb; 16(6):770-7. PubMed ID: 20135728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon treatment for hepatitis B-associated membranous glomerulonephritis in two Chinese children.
    Wong SN; Yu EC; Lok AS; Chan KW; Lau YL
    Pediatr Nephrol; 1992 Sep; 6(5):417-20. PubMed ID: 1280987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virological features of hepatitis B virus-associated nephropathy in Japan.
    Kusakabe A; Tanaka Y; Kurbanov F; Goto K; Tajiri H; Murakami J; Okuse C; Yotsuyanagi H; Joh T; Mizokami M
    J Med Virol; 2007 Sep; 79(9):1305-11. PubMed ID: 17607789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HBV and proteinuria in relatives and contacts of children with hepatitis B virus-associated membranous nephropathy.
    Bhimma R; Coovadia HM; Kramvis A; Adhikari M; Kew MC; Connolly CA
    Kidney Int; 1999 Jun; 55(6):2440-9. PubMed ID: 10354293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of hepatitis B virus-associated membranous glomerulonephritis with interferon alfa in a 7 year old boy].
    Steiss JO; Piske-Keyser K; Gröne HJ; Gortner L
    Klin Padiatr; 2000; 212(5):283-6. PubMed ID: 11048290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B-related membranous nephropathy should be treated with a specific anti-viral agent.
    Tang S; Lai KN
    Kidney Int; 2006 Aug; 70(4):818. PubMed ID: 16900222
    [No Abstract]   [Full Text] [Related]  

  • 19. Successful treatment of occult hepatitis B virus infection related membranous nephropathy after entecavir therapy.
    Xiong QF; Zhong YD; Hu ZL; Yang YF
    Acta Clin Belg; 2015 Jun; 70(3):223-5. PubMed ID: 25510219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between hepatitis B virus genotype B and C and response to interferon therapy in HBeAg positive chronic hepatitis B patients: A meta-analysis.
    Kong LN; Qin B; Ma Q; Li L; Yao Y
    J Gastroenterol Hepatol; 2014; 29(7):1387-95. PubMed ID: 24548048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.